Market Research, Strategy, and Commercial Planning

We equip clients with the knowledge to make informed, impactful decisions.

We help life sciences and health technology companies turn market insight into strategic and commercial decisions. Our work supports clients in evaluating opportunities, understanding market complexity, and shaping practical approaches to growth, positioning, and market entry.

Commercial strategy in healthcare requires more than a general view of demand. It depends on a clear understanding of the policy environment, stakeholder expectations, unmet needs, competitive dynamics, and the factors that influence adoption in real-world settings. We help clients interpret these market realities and translate them into decisions that are relevant, evidence-based, and aligned with business priorities.

Our approach is tailored to the product, market, and business context, helping clients reduce uncertainty, clarify priorities, and move forward with greater confidence.

Market research and feasibility studies
Competitive landscape and patient journey mapping
Provider, payer, patient insights
Commercialization and launch strategy
Value proposition development for products and solutions

Other Services

Clinical Research and Evidence Generation

We generate the data and insights that drive product development, approval, access, and system integration.

Clinical trials (Phase I–III)
Post-approval studies (Phase IV, RWE, registries, observational studies)
Systematic reviews and meta-analyses
Biostatistics, data management, advanced analytics
Patient-reported outcomes (PRO), quality of life research
Health economics and outcomes research (HEOR)
Comparative effectiveness, benefit-risk analysis

Regulatory Strategy and Market Access

We help clients navigate regulatory pathways and secure access for:

Pharmaceuticals
Medical devices
In vitro diagnostics
Digital health technologies

Our services include:

Regulatory strategy, dossier preparation, submission
Local adaptation of global registration files
Fast-track, orphan, and early access pathways
Health authority engagement and negotiation
Pricing strategy, cost-effectiveness, budget impact modeling
Reimbursement submissions and negotiation support
Value-based healthcare (VBHC) contracting and outcome-based payment models

Medical Affairs and Stakeholder Engagement

We help companies build scientific leadership, credibility, and trust.

KOL (Key Opinion Leader) identification and engagement
Advisory boards, expert panels, and scientific boards
Medical writing (protocols, publications, presentations)
Scientific communication strategy and materials
Medical affairs strategy and training
Internal and external education programs

Policy, Health System, and VBHC Project Support

We help clients and governments improve healthcare policy, financing, and delivery.

Evidence generation to inform clinical guidelines, reimbursement, and policy
Methodological support for national guideline development
White papers, policy briefs, and technical reports
Healthcare financing and payment reform
Public health program evaluation and optimization
Digital health evaluation, integration, and scale-up
VBHC project design, pilot development, and management with payers, providers, and governments

Special Focus:
Pharmaceutical and Medtech Clients

For pharma, biotech, medtech, diagnostics, and digital health companies, we offer an integrated pathway:

Clinical development → Market research → Commercial strategy → Regulatory approval → Pricing, HEOR, market access → Policy engagement → VBHC project management → Education, training, and stakeholder support.

We also help our clients shape the broader healthcare environment — supporting guideline development, payment model design, public health programs, and national health priorities.

Market Research, Strategy, and Commercial Planning

Other Services

Contact us